NCT06146465 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

El Hadidy TS, Alshafei AE, Mortell AE, Doherty EM
Smartphones in clinical practice: doctors' experience at two Dublin paediatric teaching hospitals. Ir J Med Sci. 2018 Aug;187(3):565-573. doi: 10.1007/s11845-017-1713-x. Epub 2017 Nov 23.
Hadjipanayis A, Klonis A, Abdel-Mannan OA, Sutcliffe AG
Smartphone use in Paediatric Practice: a national survey. J Mob Technol Med. 2016;5(1):3-8. doi:10.7309/jmtm.5.1.2
Jahn HK, Jahn IHJ, Behringer W, Lyttle MD, Roland D; Paediatric Emergency Research United Kingdom and Ireland (PERUKI)
A survey of mHealth use from a physician perspective in paediatric emergency care in the UK and Ireland. Eur J Pediatr. 2021 Aug;180(8)

Mobile Health Applications in Pediatric Patient Management: Clinicians' Perceptions, Expectations and Experiences

Clinical trial NCT06146465 - References